Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

506 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The immunologic constant of rejection.
Wang E, Worschech A, Marincola FM. Wang E, et al. Among authors: marincola fm. Trends Immunol. 2008 Jun;29(6):256-62. doi: 10.1016/j.it.2008.03.002. Epub 2008 May 3. Trends Immunol. 2008. PMID: 18457994 Review.
Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E, et al. Rivoltini L, et al. Among authors: marincola fm. J Immunol. 1995 Mar 1;154(5):2257-65. J Immunol. 1995. PMID: 7868898
Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
Marincola FM, Shamamian P, Alexander RB, Gnarra JR, Turetskaya RL, Nedospasov SA, Simonis TB, Taubenberger JK, Yannelli J, Mixon A, et al. Marincola FM, et al. J Immunol. 1994 Aug 1;153(3):1225-37. J Immunol. 1994. PMID: 8027550
Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.
Marincola FM, Ettinghausen S, Cohen PA, Cheshire LB, Restifo NP, Mulé JJ, Rosenberg SA. Marincola FM, et al. J Immunol. 1994 Apr 1;152(7):3500-13. J Immunol. 1994. PMID: 8144931 Free PMC article.
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy.
Rivoltini L, Loftus DJ, Barracchini K, Arienti F, Mazzocchi A, Biddison WE, Salgaller ML, Appella E, Parmiani G, Marincola FM. Rivoltini L, et al. Among authors: marincola fm. J Immunol. 1996 May 15;156(10):3882-91. J Immunol. 1996. PMID: 8621927
Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence of in vivo priming by tumor cells.
Marincola FM, Rivoltini L, Salgaller ML, Player M, Rosenberg SA. Marincola FM, et al. J Immunother Emphasis Tumor Immunol. 1996 Jul;19(4):266-77. doi: 10.1097/00002371-199607000-00003. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8877721
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.
Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE. Rosenberg SA, et al. Among authors: marincola fm. Nat Med. 1998 Mar;4(3):321-7. doi: 10.1038/nm0398-321. Nat Med. 1998. PMID: 9500606 Free PMC article. Clinical Trial.
Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy.
Bettinotti MP, Kim CJ, Lee KH, Roden M, Cormier JN, Panelli M, Parker KK, Marincola FM. Bettinotti MP, et al. Among authors: marincola fm. J Immunol. 1998 Jul 15;161(2):877-89. J Immunol. 1998. PMID: 9670966
Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination.
Lee KH, Panelli MC, Kim CJ, Riker AI, Bettinotti MP, Roden MM, Fetsch P, Abati A, Rosenberg SA, Marincola FM. Lee KH, et al. Among authors: marincola fm. J Immunol. 1998 Oct 15;161(8):4183-94. J Immunol. 1998. PMID: 9780192
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.
Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Sznol M, Schwarz SL, Spiess PJ, Wunderlich JR, Seipp CA, Einhorn JH, Rogers-Freezer L, White DE. Rosenberg SA, et al. Among authors: marincola fm. J Immunol. 1999 Aug 1;163(3):1690-5. J Immunol. 1999. PMID: 10415076 Free PMC article. Clinical Trial.
506 results
Jump to page
Feedback